News

Technogenetics to Offer ABL’s Genotyping Products in Italy

Jan 30, 2017

ABL acquires Fedialis Medica

Jun 24, 2016

New Diagnostics Test and Technology for Hepatitis C

May 17, 2016

Combining Ion Torrent sequencing systems and the DeepChek Suite Software

Apr 18, 2016

New commercial agreement for ViroScore® and DeepChek®

Mar 31, 2016

ABL Group launches early access program

Jul 15, 2015

A methodology to help doctors choosing the most efficient treatment for hepatitis C

Feb 16, 2015

Extension of DeepChek®-HIV portfolio with the use of PyroVir software

Jan 26, 2015

ABL signs agreement with UH Case Medical Center to offer HIV drug resistance tests

Jan 13, 2015

DeepChek®-HBV and HCV Now Available in Illumina’s BaseSpace Apps

Jan 5, 2015

ABL@ Illumina BaseSpace Worldwide Developers Conference (WWDC)

Nov 17, 2014

Initiation of a collaborative tuberculosis project

Oct 22, 2014

Collaboration on HBV genomic variations and HCC

Oct 13, 2014

Promotional Agreement with Abbott

Sep 15, 2014

New Data to be Presented at IHV 2014

Sep 5, 2014

ABL and Mayo Medical Laboratories Ink Collaboration and Licensing Agreements

Sep 2, 2014

Publication on COMET

Aug 21, 2014

DeepChek®-HIV Now Available in Illumina’s BaseSpace Apps

Aug 19, 2014

Renewal and extension with Roche Diagnostics International

Aug 19, 2014

Launch of OncoChek™

Jun 16, 2014

HepatiC® in Latin America

Jun 5, 2014

TherapyEdge® – TRePS Interface Enhance HIV Patient Management

Jun 2, 2014

The PRIUS Study in Press

Jun 1, 2014

AIDS publication on NGS and the use of DeepChek® and VisibleChek®

May 23, 2014

ABL @ NGS Round Table in Paris

May 20, 2014

ABL @ Clinical Virology Symposium ASM 2014 :: 7 presentations

May 20, 2014

EC Innovation Funding for SMEs: ABL’s experience

Nov 15, 2013

ABL and Roche Diagnostics International Signed a Collaboration Agreement to Promote their Next-Generation Sequencing, Genotyping and Drug Resistance Products

Sep 11, 2013

2013 Universal Biotech Innovation Prize!

Aug 22, 2013

ABL acquires Evivar Medical Assets and further enhances its IT Solutions and Personalized Healthcare Platform for Hepatitis B, Hepatitis C and HIV Infections

Jun 10, 2013

CE Marking for TherapyEdge®

May 29, 2013

Presentation at SEIMC 2013

May 28, 2013

ABL @ MipTec 2012

Sep 20, 2012

ABL Expands Its Research Efforts in Next Generation Sequencing with Grant Support from the Luxembourg Ministry of Economy and EUROSTARS

Sep 20, 2012

TherapyEdge®-HepatiC

Jul 11, 2012

ABL DeepChek® and ViroScore® Suite receive CE In Vitro Diagnostic mark

May 30, 2012

ABL to present at “Next-Generation Sequencing – on the way to Diagnostics with Roche”

May 11, 2012

ABL @ International Drug Resistance Workshop 2012

May 4, 2012

ABL to present at Roche Sequencing APAC User Conference

Apr 3, 2012

Presentation of DeepChek® at the European Meeting on HIV and Hepatitis

Mar 30, 2012

TALKING HEADS: A service that fills the follow-up gap

Nov 30, 2011

TherapyEdge® Chronic Care Management

Sep 2, 2011

International Workshop on HIV&HEPATITIS VIRUS

Aug 2, 2011

TherapyEdge® Launches the HIV eRegister for Windows

Aug 2, 2011

AREVIR 2011

Aug 2, 2011

EASL 2011 in Berlin

Aug 2, 2011

454 Ultra-Deep-Sequencing and the DeepChek™-HIV system

Aug 1, 2011

TherapyEdge® Liver Diseases

Aug 1, 2011

Trade News

Apr 6, 2011

ABL is partnering to the European Network TINN2

Mar 22, 2011

European Workshop on HIV & Hepatitis congress

Feb 1, 2011

FibroMeters : the most reliable tests of liver fibrosis.

Feb 1, 2011

TherapyEdge® & ViroScore® at the GeSIDA congress

Feb 1, 2011

TherapyEdge® ABL SA and BioLiveScale SA

Feb 1, 2011

BioHealth: newsletter 1

Jan 21, 2011

Comments are closed.